Core Points - The Shanghai Stock Exchange's Listing Review Committee approved the initial public offering (IPO) of Muxi Integrated Circuit (Shanghai) Co., Ltd., marking the 62nd company to pass this year [1] - Muxi's main business focuses on the research, design, and sales of full-stack GPU products for artificial intelligence training, general computing, and graphics rendering [1][2] - The company plans to issue up to 40.10 million shares, raising approximately 390.37 million yuan for various GPU development projects [2] Company Ownership - Shanghai Jiaomai holds 13.30% of Muxi's shares, making it the largest shareholder, while combined with Shanghai Xiji, they control 22.94% of the company [2] - Chen Weiliang, the managing partner of both Shanghai Jiaomai and Shanghai Xiji, is the actual controller of the company, holding significant board nomination rights [2] IPO Details - Muxi's IPO is set to take place on the Sci-Tech Innovation Board of the Shanghai Stock Exchange, with the issuance representing at least 10% of the total share capital post-issue [2] - The funds raised will be allocated to projects including the development and industrialization of high-performance general GPUs and next-generation AI inference GPUs [2] Market Position and Competition - The company was questioned during the listing review regarding its competitive advantages and potential risks in the GPU market, particularly concerning its compatibility with the CUDA ecosystem [3] - There were inquiries about the significant increase in accounts receivable and the rationale behind certain sales contract terms, indicating scrutiny over financial practices [3]

Core Viewpoint - Jiahe Meikang (688246.SH) is currently trading at 24.86 yuan, reflecting a decline of 2.09% and is in a state of breaking its initial public offering price [1] Group 1: Company Overview - Jiahe Meikang was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 14, 2021, with an initial offering price of 39.50 yuan per share [1] - The company issued a total of 34.4694 million shares during its IPO, raising a total of 1.362 billion yuan, with a net amount of 1.240 billion yuan after deducting issuance costs [1] - The final net fundraising amount exceeded the original plan by 490 million yuan [1] Group 2: Fundraising and Use of Proceeds - The company initially planned to raise 750 million yuan, which was allocated for the development of specialized electronic medical records (in emergency and maternal-child health), upgrading of comprehensive electronic medical records, data center upgrades, and to supplement working capital [1] - The total issuance costs for the IPO amounted to 121 million yuan, with the lead underwriter, Huatai United Securities Co., Ltd., receiving 97.823 million yuan in underwriting fees [1]

10月22日，智明达(688636)以简易程序向特定对象发行股票申请获上交所受理。本次预计募集资金2.08 亿元。本次发行保荐机构为华泰联合证券有限责任公司。（数据宝） （文章来源：证券时报网） ...

Core Viewpoint - Shenhao Technology announced the replacement of its sponsor representative for the ongoing supervision of its convertible bond issuance project, which is set to continue until December 31, 2024 [2] Group 1 - Shenhao Technology received a letter from Huatai United Securities regarding the change of the sponsor representative for the continuous supervision of its convertible bond issuance [2] - The original sponsor representatives, Mr. Pu Guiyang and Mr. Fan Mengzhuo, were responsible for the ongoing supervision, but Mr. Fan has been replaced due to a job transfer [2] - Ms. Si Yudi has been appointed as the new sponsor representative to ensure the orderly continuation of the supervision work [2]

证券日报网讯 10月21日晚间，振华股份发布公告称，公司于近日收到华泰联合证券有限责任公司（简 称"华泰联合"）出具的《华泰联合证券有限责任公司关于更换湖北振华化学股份有限公司向不特定对象 发行可转换公司债券持续督导保荐代表人的函》。华泰联合作为振华股份向不特定对象发行可转换公司 债券项目的保荐机构，原指派樊灿宇先生和范蒙卓先生担任保荐代表人负责持续督导工作。现因范蒙卓 先生工作调动，不再担任公司持续督导的保荐代表人。为保证持续督导工作的有序进行，华泰联合委派 耿玉龙先生接替范蒙卓先生担任公司向不特定对象发行可转换公司债券持续督导的保荐代表人，继续履 行持续督导职责。 （文章来源：证券日报） ...

Core Viewpoint - The stock of NuoVasive (688105.SH) closed at 21.96 yuan, reflecting a decline of 3.56% and currently in a state of breaking issue [1] Group 1: Company Overview - NuoVasive was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 15, 2021, with an issuance of 40.01 million shares at a price of 55.00 yuan per share [1] - The total funds raised from the initial public offering (IPO) amounted to 2.201 billion yuan, with a net amount of 2.109 billion yuan after deducting issuance costs [1] - The final net amount raised exceeded the original plan by 907 million yuan [1] Group 2: Fund Allocation - The funds raised are intended for the company's headquarters and new R&D base project, expansion of the marketing network, and to supplement working capital [1] - The total issuance costs for the IPO were 91.38 million yuan, with Huatai United Securities receiving 72.64 million yuan as underwriting and sponsorship fees [1] Group 3: Strategic Investment - Huatai Innovation Investment Co., a subsidiary of the sponsoring institution, participated in the strategic placement of the IPO, acquiring 120.03 thousand shares, which is 3% of the total issuance [1] - The lock-up period for the shares acquired by Huatai Innovation is set for 24 months, starting from the date of listing on the Shanghai Stock Exchange [1]

Core Viewpoint - Rongbai Technology (688005.SH) reported a significant decline in revenue and net profit for the first three quarters of 2025, indicating financial challenges ahead [1]. Financial Performance - For the first three quarters of 2025, the company achieved operating revenue of 8.986 billion yuan, a year-on-year decrease of 20.64% [1][3]. - The net profit attributable to shareholders was -204 million yuan, down 274.96% year-on-year [1][3]. - The net profit after deducting non-recurring gains and losses was -221 million yuan, a decline of 348.89% compared to the previous year [1][3]. - The net cash flow from operating activities was 1.371 billion yuan [1]. Comparison with Previous Year - In 2024, the company reported operating revenue of 15.088 billion yuan, a decrease of 33.41% compared to 2023 [4]. - The net profit attributable to shareholders in 2024 was 296 million yuan, down 49.06% year-on-year [4]. - The net profit after deducting non-recurring gains and losses for 2024 was 244 million yuan, a decrease of 52.64% compared to the previous year [4]. - The net cash flow from operating activities in 2024 was 523 million yuan, a significant drop of 70.85% from the previous year [4]. Fundraising and Use of Proceeds - Rongbai Technology raised a total of 1.198 billion yuan through its IPO, with a net amount of 1.101 billion yuan, of which 826 million yuan was allocated for the "2025 Power-type Lithium Battery Material Comprehensive Base (Phase I)" [5]. - The company incurred underwriting fees totaling 96.897 million yuan, with CITIC Securities receiving 80.05 million yuan as the lead underwriter [5]. Stock Issuance - The company issued 31,681,102 shares at a price of 42.11 yuan per share, raising a total of approximately 1.334 billion yuan, netting around 1.325 billion yuan after fees [6][7]. - The total amount raised from both fundraising rounds reached 2.532 billion yuan [7]. Equity Distribution - In the third quarter of 2024, the company announced a capital reserve distribution plan, where shareholders would receive 4.9 additional shares for every 10 shares held, with no cash or bonus shares distributed [7].

Core Viewpoint - The announcement details the lifting of restrictions on 1,015,417,369 shares of Beijing Shougang Co., Ltd., which will become tradable on October 20, 2025, representing 13.0938% of the company's total share capital [2][3][7]. Group 1: Basic Information on Restricted Shares - The company received approval from the China Securities Regulatory Commission on March 18, 2022, to issue shares to Shougang Group for asset acquisition and fundraising [4]. - The shares were listed on the Shenzhen Stock Exchange starting April 20, 2022, following the issuance to Shougang Group [4]. Group 2: Shareholder Commitments and Compliance - Shougang Group has fulfilled its commitments regarding the transaction, with no violations affecting the listing of the restricted shares [5]. - There are no non-operational fund occupations by Shougang Group or any violations of guarantees that would harm the company's interests [5]. Group 3: Listing Arrangement for Restricted Shares - The lock-up period for the shares will automatically extend by six months if the company's stock price remains below the issuance price for 20 consecutive trading days within six months post-transaction [6]. - The total number of shares that will be tradable is 1,015,417,369, which constitutes 13.0938% of the current total share capital [7]. Group 4: Changes in Share Capital Structure - The announcement includes details on the changes in the company's capital structure before and after the lifting of restrictions on the shares [9]. Group 5: Independent Financial Advisor's Opinion - The independent financial advisors confirmed that the lifting of restrictions on the shares complies with relevant laws and regulations, and there are no issues with the commitments made by the shareholders [9].

德力佳传动科技（江苏）股份有限公司 首次公开发行股票并在主板上市 招股意向书提示性公告 保荐人（主承销商）：华泰联合证券有限责任公司 扫描二维码查阅公告全文 德力佳传动科技（江苏）股份有限公司（以下简称"德力佳"、"发行人"或 "公司"）首次公开发行股票并在主板上市的申请已经上海证券交易所（以下简 称"上交所"）上市审核委员会审议通过，并已经中国证券监督管理委员会（以 下简称"中国证监会"）证监许可〔2025〕1800 号文同意注册。《德力佳传动科 技（江苏）股份有限公司首次公开发行股票并在主板上市招股意向书》及附录在 上海证券交易所网站（https://www.sse.com.cn）和符合中国证监会规定条件网站 （中国证券网：https://www.cnstock.com；中证网：https://www.cs.com.cn；证券 时报网：https://www.stcn.com；证券日报网：http://www.zqrb.cn；经济参考网： http://www.jjckb.cn；中国金融新闻网：https://www.financialnews.com.cn；中国日 报网：https://www.chin ...

德力佳传动科技（江苏）股份有限公司 首次公开发行股票并在主板上市 招股意向书附录 | 序号 | 文件名称 | 页码 | | --- | --- | --- | | 1 | 发行保荐书 | 1 | | 2 | 财务报告及审计报告 | 28 | | 3 | 内部控制审计报告 | 187 | | 4 | 经注册会计师鉴证的非经常性损益明细表 | 205 | | 5 | 法律意见书 | 215 | | 6 | 律师工作报告 | 580 | | 7 | 发行人公司章程（草案） | 767 | | 8 | 中国证监会同意本次发行注册的文件 | 822 | 关于德力佳传动科技（江苏）股份有限 公司 首次公开发行股票并在主板上市 之 发行保荐书 保荐人（主承销商） （深圳市前海深港合作区南山街道桂湾五路128号前海深港基金小镇B7栋401） 1 | 目 录 1 | | --- | | 第一节 本次证券发行基本情况 3 | | 一、保荐人工作人员简介 3 | | 二、发行人基本情况简介 4 | | 三、保荐人及其关联方与发行人及其关联方之间的利害关系及主要业务往来 | | 情况说明 4 | | 四、保荐人内部审核程序和内核意见 ...